The outcome of repeat cadaveric kidney transplants in recipients managed with cyclosporine.
Smith
A Y
AY
Department of Surgery, University of Texas Medical School, Houston 77030.
Van Buren
C T
CT
Lewis
R M
RM
Kerman
R H
RH
Welsh
M
M
Kahan
B D
BD
D000017:ABO Blood-Group System; D001379:Azathioprine / Q000008:administration & dosage; D001803:Blood Transfusion; D002102:Cadaver; D003524:Cyclosporins / Q000627:therapeutic use*; D006084:Graft Rejection; D006680:HLA Antigens / Q000276:immunology; D006684:HLA-DR Antigens / Q000276:immunology; D006801:Humans; D007109:Immunity; D007165:Immunosuppression Therapy / Q000379:methods; D007518:Isoantibodies / Q000276:immunology; D016030:Kidney Transplantation; D011241:Prednisone / Q000627:therapeutic use; D011379:Prognosis; D044469:Racial Groups; D012008:Recurrence
D000017:ABO Blood-Group System; D003524:Cyclosporins; D006680:HLA Antigens; D006684:HLA-DR Antigens; D007518:Isoantibodies; D001379:Azathioprine; D011241:Prednisone